Literature DB >> 30806094

Fatal intoxication with new synthetic cannabinoids AMB-FUBINACA and EMB-FUBINACA.

Piotr Adamowicz1, Ewa Meissner2, Marta Maślanka1.   

Abstract

Introduction: Synthetic cannabinoids are currently the largest group of new psychoactive substances. Those that have been subjected to legal control are replaced by newer uncontrolled substances, which causes constant and dynamic changes to the drug market. Some of the most recent synthetic cannabinoids that have appeared on the "legal highs" market are AMB-FUBINACA and EMB-FUBINACA. Case history: A 27-year-old man was found dead on a bed in an apartment. At autopsy, congestion of internal organs, pulmonary oedema and left-sided pleural adhesions were found. The medical examiner concluded that the man died due to acute respiratory failure. The autopsy materials (blood, urine, liver, kidney, stomach, intestine, lung and brain) were collected for further toxicological analyses.
Methods: The synthetic cannabinoids AMB-FUBINACA and EMB-FUBINACA were isolated from autopsy materials by precipitation with acetonitrile. The quantitative analyses were carried out by LC-MS/MS.
Results: AMB-FUBINACA and EMB-FUBINACA were detected and quantified in all post-mortem materials except the blood. The determined concentrations of these compounds in solid tissues were in the range of 0.2-0.9 ng/g and 0.2-3.5 ng/g. The highest concentrations of AMB-FUBINACA and EMB-FUBINACA were revealed in the stomach content (5.8 and 36.2 ng/mL, respectively). Discussion: The presented case demonstrates that even in cases of fatalities, it is possible that the parent substance will not be present in the blood, while being present in other autopsy materials. The determined concentrations of the compounds may indicate oral administration of synthetic cannabinoids. It can also be assumed that AMB-FUBINACA and EMB-FUBINACA probably contributed to death.
Conclusion: The presented case shows that synthetic cannabinoids can be undetected in the blood of even seriously or fatally intoxicated people. This situation means that the analysis of only blood samples may not confirm poisoning. The presented case also suggests that AMB-FUBINACA and EMB-FUBINACA use is dangerous to health and may lead to fatal intoxication.

Entities:  

Keywords:  AMB-FUBINACA; EMB-FUBINACA; Synthetic cannabinoids; concentrations; intoxication; post-mortem material

Mesh:

Substances:

Year:  2019        PMID: 30806094     DOI: 10.1080/15563650.2019.1580371

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  10 in total

1.  Quantitation of Synthetic Cannabinoid Receptor Agonists in Postmortem Blood Using a Single Point Calibration.

Authors:  Phoebe Sharp; Simon Hudson; Stephen R Morley
Journal:  Acad Forensic Pathol       Date:  2021-07-20

Review 2.  Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review.

Authors:  Amanda L A Mohr; Barry K Logan; Melissa F Fogarty; Alex J Krotulski; Donna M Papsun; Sherri L Kacinko; Marilyn A Huestis; Jeri D Ropero-Miller
Journal:  J Anal Toxicol       Date:  2022-07-14       Impact factor: 3.220

3.  An outbreak of deaths associated with AMB-FUBINACA in Auckland NZ.

Authors:  Paul L Morrow; Simon Stables; Kilak Kesha; Rexson Tse; Diana Kappatos; Rishi Pandey; Sarah Russell; Oliver Linsell; Mary Jane McCarthy; Amy Spark; Dianne Vertes; Yvonne Triggs; Sinead McCarthy; Nanise Cuthers; Richard Massey
Journal:  EClinicalMedicine       Date:  2020-07-24

4.  Fatal intoxication with new synthetic cannabinoids 5F-MDMB-PICA and 4F-MDMB-BINACA-parent compounds and metabolite identification in blood, urine and cerebrospinal fluid.

Authors:  Bogdan Tokarczyk; Agnieszka Jurczyk; Justyna Krupińska; Piotr Adamowicz
Journal:  Forensic Sci Med Pathol       Date:  2022-06-14       Impact factor: 2.456

5.  Behavioral pharmacology of five novel synthetic cannabinoids.

Authors:  Michael B Gatch; Andrew Tourigny; Ritu A Shetty; Michael J Forster
Journal:  Behav Pharmacol       Date:  2022-04-01       Impact factor: 2.293

Review 6.  Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications.

Authors:  Carolina Lobato-Freitas; Andreia Machado Brito-da-Costa; Ricardo Jorge Dinis-Oliveira; Helena Carmo; Félix Carvalho; João Pedro Silva; Diana Dias-da-Silva
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-25

7.  Cytotoxicity, metabolism, and isozyme mapping of the synthetic cannabinoids JWH-200, A-796260, and 5F-EMB-PINACA studied by means of in vitro systems.

Authors:  Tanja M Gampfer; Lea Wagmann; Anouar Belkacemi; Veit Flockerzi; Markus R Meyer
Journal:  Arch Toxicol       Date:  2021-08-28       Impact factor: 5.153

8.  Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives.

Authors:  Davide Radaelli; Alessandro Manfredi; Martina Zanon; Paolo Fattorini; Matteo Scopetti; Margherita Neri; Paolo Frisoni; Stefano D'Errico
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

Review 9.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

10.  Discovery of Orexant and Anorexant Agents with Indazole Scaffold Endowed with Peripheral Antiedema Activity.

Authors:  Marilisa P Dimmito; Azzurra Stefanucci; Stefano Pieretti; Paola Minosi; Szabolcs Dvorácskó; Csaba Tömböly; Gokhan Zengin; Adriano Mollica
Journal:  Biomolecules       Date:  2019-09-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.